Syngene International enters into partnership with Zumutor Biologics

30 May 2018 Evaluate

Syngene International has entered into a non-exclusive partnering agreement with Zumutor Biologics, an emerging immuno-oncology company, to access Zumutor’s proprietary naive human phage/yeast display library. This collaboration further enhances Syngene’s market-leading capabilities in Discovery Biology, providing its scientists with additional tools to help solve complex biology problems in biotherapeutic drug discovery.

Under the terms of the agreement, Syngene will screen target antigens against Zumutor’s proprietary human antibody libraries to identify and characterize novel antibody clones, which will be further developed by Syngene towards novel biotherapeutics programs for its partners.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.


Syngene Internation. Share Price

592.15 -8.70 (-1.45%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 592.15
Indegene 475.10
CMS Info Systems 327.30
Sagility 52.46
Smartworks Coworking 438.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×